Department of Chemistry and Biochemistry
University of California
Los Angeles, California
For nourishing the fields of synthetic, organic, and medicinal chemistry and for his discovery and development of androgen receptor antagonists including enzalutamide and apalutamide for the treatment of both pre- and post-metastatic castration-resistant prostate cancer.
Dr. Jung delivered his award lecture titled “Drug Discovery in Academia: Cancer Research,” Tuesday, April 2, 2019, during the AACR Annual Meeting 2019, at the Georgia World Congress Center.